Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block in Breast Surgery
NCT00547989Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2006
- Primary completion
- Dec 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in breast cancer, sponsored by Maastricht University Medical Center+. Started Oct 2006; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00547989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547989.